Clinical Trial Signal From $199
Pricing

Three paid tiers. Source-backed value.

Free public search. Pro for individual analysts. Analyst Desk for pipeline, patents, sponsor financial relationships, and wire-feed intelligence. Research Team for multi-seat desks that need global pharmacovigilance and ex-U.S. market-access coverage. Subscribe any time. Cancel any time.

Free
$0

Search public registries. See live trial movement, FDA safety alerts, and openFDA recalls.

  • Search ClinicalTrials.gov (top 5)
  • Live FDA MedWatch alerts
  • Latest openFDA recalls
  • ·No watchlist alerts
  • ·No exports
  • ·No AI brief
Analyst Desk
$399/month
Or $3,990/year · 2 months included

For biotech investors, equity analysts, BD teams, and competitive-intelligence groups. Adds patents, pipeline funding, KOL mapping, sponsor wires, and SEC disclosure monitoring.

  • Everything in Pro
  • USPTO PatentsView — patent-cliff & IP-portfolio mapping
  • NIH RePORTER — pre-trial pipeline visibility
  • CMS Open Payments — KOL & investigator due diligence
  • Newswire feeds (PR Newswire / GlobeNewswire / Business Wire)
  • SEC EDGAR disclosure monitoring (8-K / 10-K / 10-Q)
  • Sponsor comparison dashboards
  • 1 seat

Subscription auto-renews monthly at $399 until cancelled. Cancel any time. Agree to Terms.

Research Team
$699/month
Or $6,990/year · 2 months included

For research desks, biotech consultancies, global pharma teams, and investor groups. Adds global pharmacovigilance and ex-U.S. market-access decisions. 5 seats included.

  • Everything in Analyst Desk
  • 5 seats included (additional seats $39/seat/mo)
  • WHO VigiAccess — global pharmacovigilance
  • NICE (UK) — health-technology appraisals
  • PMDA (Japan) — approvals and safety reviews
  • Disease-area dashboards
  • Custom watchlist AI briefs
  • Priority support

Subscription auto-renews monthly at $699 until cancelled. Additional seats $39/seat/mo. Agree to Terms.

Three paid tiers, monthly or annually. Subscribe any time. Cancel any time. Annual billing includes 2 months. The free tier is always free — no account required. By subscribing you agree to our Terms and Privacy Policy.

Every signal is source-backed

Source · source URL · source published timestamp · ingested timestamp · previous value · new value · normalized signal · AI-assisted interpretation · caveat. Export PDF or CSV for any record. This is the same evidence that backs every card you see across Clinical Trial Signal.

Evidence record Example evidence record Notable
Trial primary-completion change · Phase 3 GLP-1 obesity (illustrative)
SourceClinicalTrials.gov registry
Source URLDeep link to the live NCT record (shown on real signals)
Source published2026-05-30T00:00:00Z
Ingested2026-05-30T04:12:48Z
Previous valuePrimaryCompletion = 2026-12-15
New valuePrimaryCompletion = 2027-06-15
Normalized signaltrial.primary_completion_shift · delta = +6 months · severity = notable
AI-assisted interpretationA 6-month shift on a lead Phase 3 read-out moves the sponsor's regulatory submission window out of 2026, with downstream implications for competing-program timing and BD windows.
Registry date moves do not establish cause. The sponsor has not publicly disclosed a reason in the registry record.